Ascentage Pharma Group International Ratios

Ratios Dec2022 Dec2023 Dec2024
Profitability
Gross Margin 89.51%86.24%97.03%
EBT Margin -423.05%-420.24%-40.31%
EBIT Margin 84.26%82.58%96.02%
EBITDA Margin 84.26%82.58%96.02%
Operating Margin 84.26%82.58%96.02%
Net Margin -421.02%-416.98%-41.34%
FCF Margin -408.75%-347.86%-13.83%
Efficiency
Inventory Average 1.60M
Equity Average 35.43M23.78M
Invested Capital 325.30M260.87M262.00M
Leverage & Solvency
Interest Coverage Ratio 3.351.9114.61
Times Interest Earned 3.351.9114.61
Valuation
Enterprise Value -200.42M-142.21M-122.35M
Return Ratios
Return on Sales -4.21%-4.17%-0.41%
Return on Invested Capital 0.09%
Return on Equity -3.70%-2.37%